Farxiga / Forxiga • SGLT2 inhibitor • Kidney function: Hemodialysis or peritoneal dialysis
The recommended dose of Dapagliflozin (Farxiga/Forxiga) at Hemodialysis or peritoneal dialysis — with monitoring notes for kidney disease and dialysis.
Discontinue at dialysis initiation.
Stopped when dialysis starts — no evidence of benefit at that stage. A cardiologist may continue it for heart failure in select cases.
Doses in this guide follow drug labels and renal-dosing references at each eGFR/CrCl level. Always confirm with your prescriber and pharmacy — your specific dose depends on other medications, conditions, and lab results.
Full Dapagliflozin (Farxiga/Forxiga) kidney guideDapagliflozin (Farxiga/Forxiga) has its own monitoring requirements (eGFR, potassium, drug levels, or blood counts). These become more frequent as kidney function falls. Report unusual weakness, irregular heartbeat, or new side effects promptly.
Interactive drug-dosing tool